TrialJAMA network open2024

Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19: The SCORPIO-SR Randomized Clinical Trial.

Hiroshi Yotsuyanagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.